Wednesday, April 19, 2017 10:16:00 AM
We will also be working in the field of infectious diseases as it relates to public health and try to reduce the overuse of antibiotics through differentiating between bacterial and viral infections like we're doing in our Vancouver clinical study on the NaNose. We're also working with microbiologists and epidemiologists to see if there is a potential to help stop the spread of infectious diseases at our borders that are a significant issue to the US and beyond. So, I believe that our future is very bright. I think the technology that we're developing will have enormous clinical applications and will really deliver on the promise of breath analysis for clinical use.
www.equities.com/news/breathtecs-handheld-analysis-device-getting-within-reach-ceo-guy-latorre
GUY LATORRE: THE INSIDE MAN
/////AMG
FEATURED Element79 Gold Corp Reports Exceptionally High-Grade Results from Lucero • May 14, 2024 7:00 AM
VAYK Added New Manager for Expansion into $64 Billion Domestic Short-term Rental Market • VAYK • May 14, 2024 9:00 AM
Avant Technologies Equipping AI-Managed Data Center with High Performance Computing Systems • AVAI • May 10, 2024 8:00 AM
VAYK Discloses Strategic Conversation on Potential Acquisition of $4 Million Home Service Business • VAYK • May 9, 2024 9:00 AM
Bantec's Howco Awarded $4.19 Million Dollar U.S. Department of Defense Contract • BANT • May 8, 2024 10:00 AM
Element79 Gold Corp Successfully Closes Maverick Springs Option Agreement • ELEM • May 8, 2024 9:05 AM